(NASDAQ:CINGW),(NASDAQ:CING), Jennifer Callahan, Chief Financial Officer, appointed Interim CEO Board member, Jay Roberts appointed Executive Chairman KANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) — (NASDAQ: CING) The Board of Directors of Cingulate Inc. (“Cingulate”) announced that it has placed Chairman and Chief Executive Officer, Shane J. Schaffer, PharmD, on administrative leave in connection with […]

(NASDAQ:AMIX), – Live video webcast on Thursday, August 21st at 2:20 PM ET THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced that it will present at the Webull Financial Corporate Connect Webinar Series:

Green Mountain Falls, Colorado, Aug. 15, 2025 (GLOBE NEWSWIRE) — Nestled beneath America's Mountain, Pikes Peak, Green Box invites artists from around the world to apply for its acclaimed 2026 Artist Residency Program, opening on September 2nd. Green Box, a premier and growing arts incubator, is known for transforming Colorado's Front Range into a creative

(NASDAQ:FTNT), SUNNYVALE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) — News SummaryFortinet(R) (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced that Ken Xie, Founder, Chairman and Chief Executive Officer, and Christiane Ohlgart, Chief Financial Officer, will participate in a virtual fireside chat hosted by Goldman Sachs on Monday, August

(NASDAQ:BIOA), First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; BGE-102 demonstrated robust weight loss in preclinical models, both as monotherapy and in combination with GLP-1 receptor agonists Initial Phase 1 SAD data anticipated by end of 2025, with top-line

(NYSE MKT:AIM), Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen(R) (rintatolimod) in combination with AstraZeneca's Imfinzi(R) (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no significant toxicity and superior PFS and OS Bolstered cash position provides runway to fund operations for approximately 12 months OCALA,

(NASDAQ:HSCS),(NASDAQ:HSCSW), Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its participation in multiple virtual events during the month of August. These events are intended to further introduce HeartSciences'

Cycurion, Inc. Offers Insight on Second Quarter 2025 Results and Recent Business Activities Company to host a conference call on August 19, 2025 to discuss in more detail GlobeNewswire August 15, 2025 MCLEAN, Va., Aug. 15, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a premier cybersecurity and IT solutions provider,

Turtle Beach Corporation, Together With The Donerail Group, Announces $20 Million Share Repurchase From Shareholder GlobeNewswire August 15, 2025 SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) — Turtle Beach Corporation (Nasdaq: TBCH, the “Company”), a leading gaming accessories brand, today announced it entered into a definitive agreement to repurchase 694,926 shares of common stock from

180 Degree Capital Corp. And Mount Logan Capital Inc. Provide Update on Proposed Business Combination GlobeNewswire August 15, 2025 As of August 14, 2025, in excess of 57%, or more than 90% of the approximately 63% of outstanding shares of 180 Degree Capital voted, are FOR the proposed Business Combination, and in excess of 50%